A History of Cancer Research: The P53 Pathway

Joseph Lipsick1

  • 1Departments of Pathology, Genetics, and Biology, Stanford University, Stanford, California 94305-5324, USA lipsick@stanford.edu.

Insights

The p53 tumor suppressor protein, initially mistaken as an oncogene, is crucial for preventing cancer. It acts as the "guardian of the genome," regulating DNA damage response and cell cycle control.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • The p53 protein was initially identified through its interaction with SV40 large T antigen in transformed cells.
  • Early research incorrectly suggested p53 was an oncogene product.
  • Later studies established p53 as a critical tumor suppressor protein.

Purpose of the Study:

  • To recount the historical discovery of the p53 protein.
  • To elucidate the pivotal research that defined p53's function as a tumor suppressor.
  • To highlight p53's role as the "guardian of the genome."

Main Methods:

  • Historical review of scientific literature and discoveries.
  • Analysis of experimental findings related to p53 function.
  • Tracing the evolution of understanding p53's role in cancer.

Main Results:

  • p53 was initially misidentified but later recognized as a vital anticancer protein.
  • Loss or mutation of p53 is linked to the promotion of tumorigenesis.
  • p53 functions as a DNA-binding transcription factor essential for DNA damage response and cell cycle regulation.

Conclusions:

  • The discovery and characterization of p53 represent a landmark achievement in cancer research.
  • p53's function as a tumor suppressor is fundamental to maintaining genomic stability.
  • Understanding p53's role provides critical insights into cancer development and potential therapeutic strategies.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.7K